The association between obsessive-compulsive disorder (OCD) and Tourette's/chronic tic disorders (TD/CTD) with autoimmune diseases (ADs) is uncertain. In this nationwide study, we sought to clarify the patterns of comorbidity and familial clustering of a broad range of ADs in individuals with OCD, individuals with TD/CTD and their biological relatives. From a birth cohort of 7 465 455 individuals born in Sweden between 1940 and 2007, we identified 30 082 OCD and 7279 TD/CTD cases in the National Patient Register and followed them up to 31 December 2013. The risk of 40 ADs was evaluated in individuals with OCD, individuals with TD/CTD and their first-(siblings, mothers, fathers), second-(half siblings) and third-degree (cousins) relatives, compared with population controls. Individuals with OCD and TD/CTD had increased comorbidity with any AD (43% and 36%, respectively) and many individual ADs. The risk of any AD and several individual ADs was consistently higher among first-degree relatives than among second-and third-degree relatives of OCD and TD/CTD probands. The risk of ADs was very similar in mothers, fathers and siblings of OCD probands, whereas it tended to be higher in mothers and fathers of TD/CTD probands (compared with siblings). The results suggest a familial link between ADs in general (that is, not limited to Streptococcus-related conditions) and both OCD and TD/CTD. Additional mother-specific factors, such as the placental transmission of antibodies, cannot be fully ruled out, particularly in TD/CTD.
INTRODUCTION
Immunological factors are increasingly recognized as etiologically important in a range of neuropsychiatric disorders, such as autism spectrum disorder, 1 schizophrenia 2 or bipolar disorder. 3 The potential link between immunological factors and psychiatric symptoms has been much debated in obsessive-compulsive disorder (OCD) and Tourette's/chronic tic disorders (TD/CTD) because of the still controversial link between group A Streptococcus infections and the abrupt onset of these psychiatric symptoms in a small group of children. 4, 5 One way to determine whether immunological factors are associated with OCD and/or TD/CTD is to examine whether there is increased comorbidity and family history of autoimmune diseases (ADs) in these psychiatric patients. Because ADs share some of the same risk factors (for example, cytokine dysfunction, genetic and environmental factors), [6] [7] [8] [9] tend to coexist in the same individuals and co-aggregate in the same families, [10] [11] [12] finding an above-chance prevalence of ADs in patients with OCD and/or TD/CTD and their relatives would support a possible role of the immune system in the etiology of these disorders. 13 Although the association between rheumatic fever-particularly its neurological manifestation, Sydenham's chorea-OCD and TD/CTD has been well established, the link with other classic ADs is far less clear. [13] [14] [15] [16] The previous literature has been scarce and severely limited by methodological issues, such as the study of small sample sizes mainly recruited from specialist clinics, the use of cross-sectional designs, lack of blind assessors, lack of control groups and the use of self-report measures known to have poor psychometric properties. 13 The strongest evidence of the association between AD and OCD or TD/CTD originates from a handful of family studies suggesting that the mothers of individuals with these disorders have elevated rates of AD. In a specialty clinic-based study, 17 the mothers of 107 children and adolescents with OCD and/or TD/CTD were interviewed regarding their history of ADs. Nearly 18% of the mothers reported at least one AD; this figure was higher for the mothers of children fulfilling likely criteria for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection) (n = 40; 25%) compared with the mothers of children with unlikely PANDAS (n = 67; 13.4%). A longitudinal population-based study from Denmark examined the risk of TD (n = 2442) in the offspring of mothers with 31 different ADs. A maternal history of ADs was found in 110 cases, corresponding to an increased risk of TD of ∼ 22%. The most common maternal ADs were ulcerative colitis, rheumatoid arthritis, thyrotoxicosis and multiple sclerosis, although power was limited to examine the risk for many of the individual ADs. 18 In two case-control family studies that analyzed the same Brazilian sample using different statistical approaches, 19, 20 the rate of OCD and related disorders, including tic disorders, was significantly higher among first-degree relatives of individuals with rheumatic fever than among firstdegree relatives of controls (14.7% vs 7.3%), 19 and the risk of OCD and related disorders was increased by the presence of either rheumatic fever or Sydenham's chorea in another family member. 20 Conversely, another family study 21 found no significant differences in the rates of OCD in 72 mothers of children and adolescents with inflammatory bowel disease, compared with 44 mothers of children and adolescents with cystic fibrosis (a nonautoimmune genetic disease).
Taken together, the results of these family studies support the hypothesis that immunological factors may play a role in the etiology of at least some individuals with OCD and/or TD/CTD, but these findings require replication in large population-based samples. Furthermore, the nature of such association, if confirmed, is yet to be established. One possibility is that OCD and TD/CTD share genetic risk factors with AD. If the shared genetic risk hypothesis were correct, we would expect that the link between AD and these neuropsychiatric syndromes is not limited to only mothers but also other first-degree relatives. Furthermore, we would expect that the risks decrease with increasing genetic distance (for example, the risks for first-degree relatives should be higher than those for second-and third-degree relatives). An alternative-and perhaps not mutually exclusive-hypothesis is that mothers transmit antibodies to their offspring via the placenta. 22, 23 If the maternal transmission hypothesis were correct, we would expect that the risk for mothers would be significantly higher than the risk for fathers and other first-degree relatives.
In this study, we analyzed data from a large birth cohort of OCD and TD/CTD cases derived from the Swedish population-based registers to address the following four questions. (1) Are patients with OCD and/or TD/CTD more likely to have comorbid AD compared with population controls? (2) Are biological relatives of patients with OCD and/or TD/CTD more likely to have AD compared with relatives of unaffected individuals? (3) Does the familial risk decrease with increasing genetic distance?; (4) Do mothers have higher risks than fathers or other first-degree relatives?
MATERIALS AND METHODS

Study design
We conducted a population-based birth cohort study to examine the comorbidity and familial clustering between AD and OCD and between AD and TD/CTD. We linked information from various Swedish national registers using the unique personal identification number, a national registration number assigned to each Swedish citizen at birth or immigration. 24 These national registration numbers are randomly replaced with unique sequence numbers when register data are used for research purposes.
The Stockholm Regional Ethical Review Board approved the study (2013/862-31/5). The requirement for informed consent was waived because the study was register based and the included individuals were not identifiable at any time.
Study cohort
We selected a cohort of individuals born between 1940 and 2007 and followed them up until 31 December 2013. We excluded individuals who died or emigrated before the age of 10 years. Information about migration and death was derived from the Total Population Register and the Cause of Death Register.
Individuals with OCD and TD/CTD were identified in the National Patient Register (NPR) using previously validated algorithms. 25 The NPR includes psychiatric inpatient discharge diagnoses in Sweden since 1973, recorded according to the International Classification of Diseases (ICD) 8th, 9th and 10th editions. [26] [27] [28] [29] Since 2001, the register also includes information about psychiatric outpatient care.
The outcomes were diagnoses of 40 widely accepted ADs 30 in the index person and in relatives of an index person identified in the NPR (listed in Supplementary Table 1, together with their corresponding ICD codes). Additional analyses were conducted on specific ADs that were most prevalent in the NPR and had sufficient number of observations for analysis (410 affected individuals). Many of the ICD codes for individual ADs in the NPR have been subject of validation studies and found to have high validity. 29, 31, 32 Information about relatives was derived from the Multi-Generation Register that contains information about biological parents of an index person. A prerequisite for being included in the register is that the index person was born after 1 January 1932 and ever registered as living in Sweden after 1960. For immigrants to Sweden, similar information exists for those who became citizens before 18 years of age together with one or both parents. The biological father of the offspring is assumed to be the husband of the mother at the time of birth or identified 'by acknowledgment' for unwed mothers. 24 
Statistical analyses
Data managing and analyses were conducted in SAS statistical software version 9.4 (SAS Institute, Cary, NC, USA) and Stata IC/14.1 (College Station, TX, USA). We estimated odds ratios (ORs) to quantify the association between OCD and TD/CTD and AD with logistic regression analyses. All statistical tests employed two-sided 5% level of significance and associated two-sided 95% Wald-type confidence intervals (CIs) were calculated. We employed the robust variance estimator (sandwich estimator) to handle clustering of data.
Individual-level analyses
First, we estimated the risk of any AD in individuals with a diagnosis of OCD, and separately in individuals with a diagnosis of TD/CTD. Individuals born between 1940 and 2007 with a lifetime diagnosis of OCD or TD/CTD were considered exposed and those without these disorders were considered unexposed. We also examined the risk of individual AD in patients with OCD and TD/CTD (those with 410 observations). All analyses adjusted for birth year and gender.
Family-level analyses
We first linked information about biological parents to our cohort and analyzed the risk of any AD (and also specific AD) in parents of individuals affected with OCD and TD/CTD compared with parents of unaffected individuals. For the sibling and cousin analyses we used the same birth cohort as when studying the individual risk (born between 1940 and 2007). Full siblings were defined as individuals who share two biological parents and half siblings were defined as individuals who share one parent. Cousin analyses only included full cousins, defined as having a common grandfather and grandmother. All analyses adjusted for birth year and gender of the index person as well as for birth year of the parent/sibling /cousin.
Sensitivity analyses
In order to ensure that we studied the independent transmission of these conditions, all family analyses were repeated excluding OCD and TD/CTD probands with diagnosed AD as well as relatives with either OCD or TD/ CTD. In addition, individual-level and family-level analyses for any AD were repeated on a subgroup of individuals born between 1963 and 1983 to ensure complete follow-up from age 10 to at least age 30 years, thus avoiding issues with left truncation (that is, exposure and/or outcome happening before the register started and thus missing) and right censoring (that is, study ending when individuals were still young).
We also repeated the individual-and family-level analyses for any AD excluding individuals diagnosed before 2001, date from which outpatients were first included in the register, to ensure that more severe patients (that is, inpatients) were not biasing the results.
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RESULTS
Study cohort
The cohort included a total of 7 465 455 unique individuals of whom 30 082 had a diagnosis of OCD and 7279 had a diagnosis of TD/CTD. Moreover, our cohort included 7 416 593 individuals with information about both biological parents, 10 670 459 full sibling pairs, 1 420 623 maternal half sibling pairs, 1 841 737 paternal half sibling pairs and 25 856 102 cousin pairs.
Individual-level analysis Individuals with OCD had a 43% increased risk of any AD, compared with individuals without OCD (OR = 1.43, 95% CI = 1.37-1.49; Table 1 ). In the analyses of individual ADs, the risk was significantly elevated for Sjögren's syndrome (94% increase), celiac disease (76%), Guillain-Barré syndrome (71%), Crohn's disease (66%), Hashimoto's thyroiditis (59%), type 1 diabetes mellitus (56%), scarlet fever (52%), idiopathic thrombocytopenic purpura (51%), ulcerative colitis (41%), multiple sclerosis (41%) and psoriasis vulgaris (32%). Other ADs (for example, systemic lupus erythematosus or acute disseminated encephalomyelitis) were also associated with OCD, but power was limited, resulting in wide CIs.
Similarly, individuals with TD/CTD were 36% more likely to be affected with any AD than members of the same cohort without TD/CTD (OR = 1.36, 95% CI = 1.22-1.51; Table 1 ). In the analyses of individual ADs, the highest risk was found for Hashimoto's thyroiditis (106% increase), celiac disease (67%), scarlet fever (62%), type 1 diabetes mellitus (37% increase) and psoriasis vulgaris (33% increase). Other ADs, such as Crohn's disease or vitiligo, were also associated with TD/CTD, but CIs were wide because of limited statistical power.
Family-level analysis When examining the risk of any AD in relatives of index persons with OCD, compared with relatives of persons who did not have OCD, we found that the association was strongest and statistically significant among first-degree relatives (Table 2) . Mothers, fathers and full siblings of individuals with OCD were each significantly more likely to be affected with an AD. The risk was marginally higher among mothers (17% increase) and siblings (16% increase) than among fathers (8% increase), but CIs overlapped. The associations between OCD and AD in second-degree relatives (maternal or paternal half siblings) or in cousins were lower than for first-degree relatives and none were statistically significant ( Table 2) . Family-level analyses of individual AD followed the same general pattern (Supplementary Table 2 ).
Individuals with TD/CTD were statistically significantly more likely to have a first-degree relative with any AD ( Table 2 ). The effect was highest among mothers of individuals diagnosed with TD/CTD (40% increased risk), followed by fathers (31% risk) and siblings (17% risk), but CIs overlapped. Furthermore, second-and third-degree relatives of individuals with TD/CTD did not have a significantly elevated risk of AD (Table 2) . Family-level analyses of Table 3 ).
In an exploratory post hoc analysis, we examined whether individuals with both OCD and TD/CTD (OCD+TD/CTD; n = 1276) had similar comorbidity and familial risks of ADs. The results revealed that these individuals had similar comorbidity (OR = 1.48) to that reported in the main analyses above. The familial estimates were similar to those of TD/CTD probands, with one exception: the risk of AD in siblings was somewhat higher among OCD + TD/CTD probands (OR = 1.38). However, these results need to be interpreted cautiously given the small sample size and wide CIs (only 99 siblings of OCD+TD/CTD probands had at least one AD; Supplementary Table 4 Table 6 ) and in the subcohort of patients diagnosed from 2001 (Supplementary Table 7) .
DISCUSSION
In this total-population, multigenerational family study we found that both OCD and TD/CTD are highly comorbid with a broad range of ADs across all organ systems. Specifically, individuals with OCD were 43% more likely, and individuals with TD/CTD 36% more likely, to have any comorbid AD, compared with unaffected individuals from the general population. Analyses exclude any AD among probands as well as OCD or TD/ CTD in the relatives (full data available in Supplementary Table 5 ).
Gray shapes indicate probands, red shapes first-degree relatives, green shapes second-degree relatives, and yellow shapes thirddegree relatives. AD, autoimmune diseases; CI, confidence interval; CTD, chronic tic disorder; OCD, obsessive-compulsive disorder; OR, odds ratio; TD, Tourette's disorder.
In patients with OCD, most individual ADs showed an increased comorbidity rate, but the association was strongest for Sjögren's syndrome (94% increase), celiac disease (76%), Guillain-Barré syndrome (71%), Crohn's disease (66%), Hashimoto's thyroiditis (59%), type 1 diabetes mellitus (56%), scarlet fever (52%), idiopathic thrombocytopenic purpura (51%), ulcerative colitis (41%) multiple sclerosis (41%) and psoriasis vulgaris (32%). Similarly, in TD/CTD, many individual ADs showed an association but, because of modest statistical power for some of the rarest AD, this only reached statistical significance for Hashimoto's thyroiditis (106% increase), celiac disease (67%), scarlet fever (62%), type 1 diabetes mellitus (37%) and psoriasis vulgaris (33%). These results expand our previous knowledge on the subject-as previous studies had been limited by a range of methodological issues 13 and suggest that there is a clear association between both OCD and TD/CTD and ADs in general that is not limited to streptococcal-related conditions.
The family analyses revealed significantly elevated risk of AD in first-degree relatives of both OCD and TD/CTD patients, but not in second-or third-degree relatives. The magnitude of the results was highest for first-degree relatives of TD/CTD probands. The results were unchanged when we excluded OCD and TD/CTD probands with diagnosed AD, as well as relatives with either OCD or TD/CTD, and in various sensitivity analyses. Although our design does not allow us to confidently rule out shared environmental factors, the pattern of results is compatible with a possible shared genetic etiology between OCD and TD/CTD and ADs, at least in some patients. First, the association was only statistically significant among first-degree relatives. Second, siblings of probands had similar (OCD) or lower (TD/CTD) risks of AD than mothers and fathers (they all share ∼ 50% of the genes) despite siblings sharing more of the environment (siblings are born in the same family, during a similar period of time and grow up in the same household). Furthermore, maternal and paternal half siblings (both sharing 25% of genes but paternal half siblings potentially sharing less environment, as 490% of Swedish children continue living with their mothers after a divorce) 33 had very similar risks of ADs. Consistent with a potential genetic mechanism, a recent study using publicly available genome-wide association study data to explore the genetic correlations between a range of psychiatric and medical phenotypes with immunological and/or inflammatory disorders 34 revealed significant positive genetic correlations (uncorrected for multiple testing ± s.e.) between OCD and celiac disease (r g = 0.43 ± 0.17), negative correlations between OCD and type 1 diabetes mellitus (r g = 0.32 ± 0.11), positive correlations between TD/CTD and psoriasis (r g = 0.25 ± 0.09) and between TD/CTD and allergy (r g = 0.24 ± 0.05). 34 It should be noted that the currently published genome-wide association studies for OCD 35, 36 and TD, 37 as well as some ADs, are underpowered to detect genome-wide significant associations and much larger studies are needed. For example, it remains unclear whether OCD or TD/CTD are associated with variation in the major histocompatibility complex region on chromosome 6 that has a major influence on risk for many ADs.
Future molecular genetic studies should focus on collection of DNA from large numbers of OCD and TD/CTD cases with rich clinical and environmental risk factor information (for example, personal and family history of AD, documented temporality between infection and symptom onset). At least one study of this type is currently ongoing in TD/CTD. 38, 39 In addition, comparison of genetic markers in patients with vs without additional neurological or immunological symptoms (PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)/PANDAS) may yield mechanistic insight. Given the complexity of these psychiatric and immunological traits, well-powered analyses are key to robust findings. An excellent demonstration of this comes from a recent analysis 40 of genome-wide association study data for 460 000 cases and controls representing three adult psychiatric disorders: schizophrenia, major depression and bipolar disorder. The authors searched for biological pathways enriched for psychiatric risk variants and found that multiple immune signaling pathways were among the most robustly associated, providing a mechanistically informative link between genetic and epidemiological studies for these disorders.
Mothers, fathers and full siblings of individuals with OCD and TD/CTD were each more likely to be affected with an AD compared with unaffected individuals from the general population. In some analyses, particularly in TD/CTD, the risk was slightly higher among mothers than among fathers and siblings, but these differences were not statistically significant, as indicated by the overlapping CIs. These findings confirm and extend previous studies that focused exclusively on mothers, 17, 18 and suggest that although maternal-specific factors cannot be fully ruled out, particularly in TD/CTD, such as the placental transmission of antibodies to the offspring-which may in turn activate the immune system in the child and alter normal brain development 18 -genetic factors appear to be important. Given the increased attention to maternal immune activation in neuropsychiatric disorders, 41, 42 future studies could examine whether maternal infection and active AD during pregnancy are associated with an increased risk of OCD and TD/CTD in their offspring and how this risk varies as a function of interaction with genetic and other environmental risk factors.
Strengths and limitations
The main strengths of this study include the uniquely large population-based cohorts of OCD and TD/CTD patients that generally provided sufficient power to address the primary study questions, the inclusion of different kinds of biological relatives with differing degrees of shared genetic liability and shared environment, the long-term perspective (most previous studies have been cross-sectional) and the fact that the Swedish ICD codes for OCD, TD/CTD and many of the ADs have been formally validated. 25, 29, 31, 32 The results need to be interpreted in light of some limitations. First, despite the large cohorts, power was still limited for several of the individual ADs, particularly Streptococcus-related diseases (such as rheumatic fever with or without chorea), which means that we could not calculate some of the specific risks or these resulted in less precise estimates (wide CIs). Second, because the Swedish versions of ICD-8 and ICD-9 do not differentiate between type 1 and type 2 diabetes mellitus, we only included individuals diagnosed with type 1 diabetes mellitus according to ICD-10, resulting in the exclusion of older cases diagnosed before ICD-10 was introduced in Sweden (1997). Third, our cohorts do not represent the totality of all OCD and TD/CTD patients in Sweden; many sufferers do not seek help, the coverage of the register before 2001 is incomplete and patients diagnosed by general practitioners and nonmedical specialists are not included. In contrast, ADs may be more likely to be seen by specialist physicians in Sweden, resulting in better coverage in the patient register.
Clinical implications
It may be sensible to routinely screen for and document comorbid ADs and family history of ADs in all patients with OCD and TD/ CTD, particularly-but not exclusively-in those presenting with the constellation of symptoms commonly referred to as PANS or PANDAS. Long-term follow-up of these patients may provide useful clues regarding their prognosis compared with patients without a personal or familial link to ADs. Whether patients with an AD link respond differently or preferentially to conventional evidence-based treatments is another interesting question for the future. As knowledge advances, it may be possible to identify robust biomarkers to help guide the clinical management of those patients.
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